United States · FDA National Drug Code directory
Flecainide Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72789-383_4bc0370f-21ea-1acb-e063-6394a90ad768
- Product NDC
- 72789-383
- Form
- TABLET
- Composition / generic term
- flecainide acetate
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240111
- Source listing expiry
- 20271231
Source-listed ingredients
- FLECAINIDE ACETATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (72789-383-01) · 72789-383-01
- 60 TABLET in 1 BOTTLE, PLASTIC (72789-383-60) · 72789-383-60
- 180 TABLET in 1 BOTTLE, PLASTIC (72789-383-93) · 72789-383-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →